trending Market Intelligence /marketintelligence/en/news-insights/trending/uJdJ4qxrGUngzilpTEXWhQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Healthpeak buys class A lab building from The Davis Cos. for $332.5M

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate CRE Sector Feels the Impact of the Coronavirus

Credit Analytics Case Study Poundworld Retail Ltd


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Healthpeak buys class A lab building from The Davis Cos. for $332.5M

Healthcare-focused real estate investment trust Healthpeak Properties Inc. purchased the Alewife Research Center in West Cambridge, Mass., from The Davis Cos. Inc. for $332.5 million, according to the Boston Business Journal.

The 224,305-square-foot property, consisting of a class A lab building and 331-space parking garage, at 35 CambridgePark Drive is fully leased to five biopharmaceutical and biotech companies Eisai, Syros Pharmaceuticals, Ribon Therapeutics, Codiak BioSciences and Glympse Bio, the publication said.